|
Volumn 45, Issue 5, 2010, Pages 1731-1738
|
PEG-scutellarin prodrugs: Synthesis, water solubility and protective effect on cerebral ischemia/reperfusion injury
|
Author keywords
Cerebral ischemia reperfusion injury; Half life; Middle cerebral artery occlusion model; PEG scutellarin prodrugs; Scutellarin
|
Indexed keywords
CARBOXYL GROUP;
MACROGOL;
NIMODIPINE;
PHENOL;
PRODRUG;
SCUTELLAREIN;
SCUTELLAREIN 4' POLYETHYLENE GLYCOL SUCCINATE ESTER DERIVATIVE;
SCUTELLAREIN POLYETHYLENE GLYCOL AMIDE DERIVATIVE;
UNCLASSIFIED DRUG;
WATER;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BRAIN ISCHEMIA;
CHEMICAL MODIFICATION;
CONTROLLED STUDY;
DISEASE MODEL;
DRUG HALF LIFE;
DRUG SOLUBILITY;
DRUG SYNTHESIS;
HEART PROTECTION;
MALE;
MIDDLE CEREBRAL ARTERY OCCLUSION;
MOLECULAR WEIGHT;
NEUROLOGIC DISEASE;
NEUROPROTECTION;
NONHUMAN;
RAT;
REPERFUSION INJURY;
SCORING SYSTEM;
ANIMALS;
APIGENIN;
DISEASE MODELS, ANIMAL;
DRUG EVALUATION, PRECLINICAL;
GLUCURONIC ACIDS;
INFARCTION, MIDDLE CEREBRAL ARTERY;
MOLECULAR STRUCTURE;
MOLECULAR WEIGHT;
POLYETHYLENE GLYCOLS;
PRODRUGS;
RATS;
RATS, SPRAGUE-DAWLEY;
REPERFUSION INJURY;
SOLUBILITY;
STEREOISOMERISM;
WATER;
|
EID: 77949492719
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2010.01.006 Document Type: Article |
Times cited : (37)
|
References (31)
|